[1] 范竞一,王策.川崎病冠状动脉病变危险因素的研究进展[J].中国小儿急救医学,2023,30(3):217-220. [2] SAHASHI Y,KAWASAKI M,OKUBO M,et al.Development of 60 MHz integrated backscatter intravascular ultrasound and tissue characterization of attenuated signal coronary plaques that cause myocardial injury after percutaneous coronary intervention[J].Heart Vessels,2022,37(10):1689-1700. [3] ZHENG Y,HUANG S,ZHANG J,et al.Melatonin alleviates vascular endothelial cell damage by regulating an autophagy-apoptosis axis in Kawasaki disease[J].Cell Prolif,2022,55(6):e13251. [4] 娄萍,张雪梅,张丹,等.不同冠状动脉损伤程度川崎病患儿发病早期超声心动图、左心室心肌做功参数研究[J].实用心脑肺血管病杂志,2023,31(3):113-116. [5] GALLEGO D F,RUIZ M E Z,MARSHALL D A.Oblivion:Autopsy findings of a 31-year-old man with sudden cardiac arrest,a case report of a sequalae of Kawasaki disease[J].Autops Case Rep,2022,(12):e2021404. [6] GRIFFIN J P,POWELL A R,BHAGAT P H,et al.A preliminary,single-center retrospective chart review of infusion times of intravenous immune globulin in Kawasaki Disease and clinical outcomes[J].J Pediatr Pharmacol Ther,2022,27(5):415-418. [7] 陈敬师,张英谦,李博,等.血栓弹力图在川崎病患儿冠状动脉病变及阿司匹林抗血小板疗效评估中的应用[J].中国医药,2023,18(1):21-25. [8] SUN H,LU H,WU Y.Efficacy of gamma globulins in children with Kawasaki disease and factors influencing children's Sshort-term prognosis[J].Comput Math Meth Med,2022(2022):1-6. [9] ZHENG H,FU L,XU Y,et al.The PTGS1(rs1330344)CC genotype contributes to susceptibility to Kawasaki disease in Southern Chinese children[J].Angiology,2023,74(9):832-839. [10] 吴锐,肖长水,陈山.CRP、ESR、CKMB和BNP联合检测评估川崎病患儿合并冠脉病变的价值[J].分子诊断与治疗杂志,2023,15(4):594-597,601. [11] 黄殷,潘志伟,阳池娇,等.红细胞分布宽度和N末端心房脑钠肽前体对婴儿川崎病的诊断价值及预后研究[J].中国妇幼保健,2023,38(9):1607-1610. [12] 邱佳韵,周国平.川崎病冠状动脉损伤机制免疫遗传研究进展[J].临床儿科杂志,2023,41(1):66-72. [13] 钱翠平,黄晓碧,赵胜,等.儿童川崎病冠状动脉损伤危险因素Logistic回归分析[J].安徽医科大学学报,2023,58(3):490-494. [14] HU J,ZHENG Q,REN W.Evaluation of left ventricular myocardial stratified strain in patients with Kawasaki disease using two-dimensional speckle tracking imaging[J].Front Cardiovasc Med,2022(9):899945. [15] KARUNAKAR P,RAMAMOORTHY J G,ANANTHARAJ A,et al.Clinical profile and outcomes of multisystem inflammatory syndrome in children(MIS-C):Hospital-based prospective observational study from a tertiary care hospital in South India[J].J Paediatr Child Health,2022,58(11):1964-1971. [16] 王淑敏,李雪军,张奕星,等.肺炎支原体感染与小儿皮肤黏膜淋巴结综合征发生冠状动脉损伤相关性的Meta分析[J].中国全科医学,2023,26(20):2532-2539. [17] 孙骊珠,凌艳萍,俞海国,等.川崎病患儿并发冠状动脉损伤的危险因素及风险预测指标模型的评价与构建[J].现代生物医学进展,2023,23(2):283-288. [18] NAKAYAMA H,INADA H,INUKAI T,et al.Recombinant human soluble Thrombomodulin suppresses arteritis in a mouse model of Kawasaki disease[J].J Vasc Res,2022,59(3):176-188. [19] QIU Y,ZHANG Y,LI Y,et al.Molecular mechanisms of endothelial dysfunction in Kawasaki-disease-associated vasculitis[J].Front Cardiovasc Med,2022(9):981010. [20] 孙飞,何青,蔡慧琳.川崎病患儿血清单核细胞趋化蛋白-1的变化及临床意义[J].浙江临床医学,2023,25(1):132-133,137. [21] 闵丽,袁时健,刘亚红,等.川崎病患儿血浆YKL-40、CRP、IL-6对急性期冠状动脉损伤的诊断价值[J].疑难病杂志,2023,22(4):367-372. |